In community-acquired pneumonia, adding oral clarithromycin to standard care increased early clinical response

Henry S. Sacks

doi:10.7326/J24-0022

In community-acquired pneumonia, adding oral clarithromycin to standard care increased early clinical response

Henry S. Sacks

Research output: Contribution to journal › Article › peer-review

Abstract

SOURCE CITATION: Giamarellos-Bourboulis EJ, Siampanos A, Bolanou A, et al. Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2024;12:294-304. 38184008.

Original language	English
Pages (from-to)	JC51
Journal	Annals of Internal Medicine
Volume	177
Issue number	5
DOIs	https://doi.org/10.7326/J24-0022
State	Published - 1 May 2024

Access to Document

10.7326/J24-0022

Cite this

@article{85fa92abd4014a368f6b5ea270b5ec21,

title = "In community-acquired pneumonia, adding oral clarithromycin to standard care increased early clinical response",

abstract = "SOURCE CITATION: Giamarellos-Bourboulis EJ, Siampanos A, Bolanou A, et al. Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2024;12:294-304. 38184008.",

author = "Sacks, \{Henry S.\}",

year = "2024",

month = may,

day = "1",

doi = "10.7326/J24-0022",

language = "English",

volume = "177",

pages = "JC51",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "5",

}

TY - JOUR

T1 - In community-acquired pneumonia, adding oral clarithromycin to standard care increased early clinical response

AU - Sacks, Henry S.

PY - 2024/5/1

Y1 - 2024/5/1

N2 - SOURCE CITATION: Giamarellos-Bourboulis EJ, Siampanos A, Bolanou A, et al. Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2024;12:294-304. 38184008.

AB - SOURCE CITATION: Giamarellos-Bourboulis EJ, Siampanos A, Bolanou A, et al. Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2024;12:294-304. 38184008.

UR - https://www.scopus.com/pages/publications/85194014040

U2 - 10.7326/J24-0022

DO - 10.7326/J24-0022

M3 - Article

C2 - 38710079

AN - SCOPUS:85194014040

SN - 0003-4819

VL - 177

SP - JC51

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 5

ER -

In community-acquired pneumonia, adding oral clarithromycin to standard care increased early clinical response

Abstract

Access to Document

Fingerprint

Cite this